A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet

被引:9
作者
Miyaoka, Yuta [1 ]
Jin, Denan [2 ]
Tashiro, Keitaro [1 ]
Masubuchi, Shinsuke [1 ]
Ozeki, Maiko [1 ]
Hirokawa, Fumitoshi [1 ]
Hayashi, Michihiro [1 ]
Takai, Shinji [2 ]
Uchiyama, Kazuhisa [1 ]
机构
[1] Osaka Med Coll, Dept Gen & Gastroenterol Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
[2] Osaka Med Coll, Grad Sch Med, Dept Innovat Med, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
基金
日本学术振兴会;
关键词
chymase; fibrosis; hamster; nonalcoholic steatohepatitis; steatosis; CHYMASE INHIBITOR PREVENTS; CHOLINE-DEFICIENT DIET; LIVER-DISEASE; MAST-CELLS; RAT MODEL; FIBROSIS; PROGRESSION; ACTIVATION; SURVIVAL; THERAPY;
D O I
10.1538/expanim.17-0126
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Nonalcoholic steatohepatitis (NASH), in which there is steatosis and fibrosis in the liver, is linked to metabolic syndrome and progresses to hepatic cirrhosis. In this study, a novel hamster NASH model derived from metabolic syndrome was made using hamsters. Hamsters were fed a normal or a high-fat and high-cholesterol (HFC) diet for 12 weeks. Body weight and the ratio of liver weight to body weight were significantly greater in HFC diet-fed hamsters than in normal diet-fed hamsters. Triglyceride, low-density lipoprotein cholesterol, and glucose levels in blood were significantly increased in HFC diet-fed hamsters, and blood pressure also tended to be high, suggesting that the HFC diet-fed hamsters developed metabolic syndrome. Hepatic steatosis and fibrosis were observed in liver sections of HFC diet-fed hamsters, as in patients with NASH, but they were not seen in normal diet-fed hamsters. Chymase generates angiotensin II and transforming growth factor (TGF)-beta, both of which are related to hepatic steatosis and fibrosis, and a significant augmentation of chymase activity was observed in livers from HFC diet-fed hamsters. Both angiotensin II and TGF-beta were also significantly increased in livers of HFC diet-fed hamsters. Thus, HFC diet-fed hamsters might develop metabolic syndrome-derived NASH that clinically resembles that in NASH patients.
引用
收藏
页码:239 / 247
页数:9
相关论文
共 22 条
  • [11] Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet
    Miyaoka, Yuta
    Jin, Denan
    Tashiro, Keitaro
    Komeda, Koji
    Masubuchi, Shinsuke
    Hirokawa, Fumitoshi
    Hayashi, Michihiro
    Takai, Shinji
    Uchiyama, Kazuhisa
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 134 (03) : 139 - 146
  • [12] Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis
    Ota, Tsuguhito
    Takamura, Toshinari
    Kurita, Seiichiro
    Matsuzawa, Naoto
    Kita, Yuki
    Uno, Masafumi
    Akahori, Hiroshi
    Misu, Hirofumi
    Sakurai, Masaru
    Zen, Yoh
    Nakanuma, Yasuni
    Kaneko, Shuichi
    [J]. GASTROENTEROLOGY, 2007, 132 (01) : 282 - 293
  • [13] Green Tea Extract Suppresses NFκB Activation and Inflammatory Responses in Diet-Induced Obese Rats with Nonalcoholic Steatohepatitis
    Park, Hea Jin
    Lee, Ji-Young
    Chung, Min-Yu
    Park, Young-Ki
    Bower, Allyson M.
    Koo, Sung I.
    Giardina, Charles
    Bruno, Richard S.
    [J]. JOURNAL OF NUTRITION, 2012, 142 (01) : 57 - 63
  • [14] The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels
    Park, Hyohun
    Hasegawa, Goji
    Shima, Toshihide
    Fukui, Michiaki
    Nakamura, Naoto
    Yamaguchi, Kanji
    Mitsuyoshi, Hironori
    Minami, Masahito
    Yasui, Kohichiroh
    Itoh, Yoshito
    Yoshikawa, Toshikazu
    Kitawaki, Jo
    Ohta, Mitsumiro
    Obayashi, Hiroshi
    Okanoue, Takeshi
    [J]. CLINICA CHIMICA ACTA, 2010, 411 (21-22) : 1735 - 1740
  • [15] A novel chymase inhibitor, 4-[1-{[bis-(4-methyl-phenyl)methyl]-carbamoyl}-3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters
    Takai, S
    Jin, D
    Sakaguchi, M
    Katayama, S
    Muramatsu, M
    Sakaguchi, M
    Matsumura, E
    Kim, S
    Miyazaki, M
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01) : 17 - 23
  • [16] Chymase inhibition improves vascular dysfunction and survival in stroke-prone spontaneously hypertensive rats
    Takai, Shinji
    Jin, Denan
    Chen, Hong
    Li, Wen
    Yamamoto, Hideyuki
    Yamanishi, Kyosuke
    Miyazaki, Mizuo
    Higashino, Hideaki
    Yamanishi, Hiromichi
    Okamura, Haruki
    [J]. JOURNAL OF HYPERTENSION, 2014, 32 (08) : 1637 - 1649
  • [17] Multiple Mechanisms for the Action of Chymase Inhibitors
    Takai, Shinji
    Jin, Denan
    Miyazaki, Mizuo
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 (03) : 311 - 316
  • [18] Chymase inhibitor prevents the nonalcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet
    Tashiro, Keitaro
    Takai, Shinji
    Jin, Denan
    Yamamoto, Hiromi
    Komeda, Koji
    Hayashi, Michihiro
    Tanaka, Kazuhiko
    Tanigawa, Nobuhiko
    Miyazaki, Mizuo
    [J]. HEPATOLOGY RESEARCH, 2010, 40 (05) : 514 - 523
  • [19] Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
    Tilg, Herbert
    Moschen, Alexander R.
    [J]. HEPATOLOGY, 2010, 52 (05) : 1836 - 1846
  • [20] Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
    Tiniakos, Dina G.
    Vos, Miriam B.
    Brunt, Elizabeth M.
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2010, 5 : 145 - 171